Gut microbiota and metabolic-associated steatosis liver disease: Unveiling mechanisms and opportunities for therapeutic intervention

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 4

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Experimental Medicine

ISSN

2220-315x

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Exp Med. Dec 20, 2025; 15(4): 107316
Published online Dec 20, 2025. doi: 10.5493/wjem.v15.i4.107316

Full Size Figure Download Figure

Figure 2 Schematic summary of the bidirectional communication in the gut–liver axis.

Citation: Rusman RD, Akil F, Parewangi ML, Daud NA, Bachtiar R, Kusuma SH, Rifai A. Gut microbiota and metabolic-associated steatosis liver disease: Unveiling mechanisms and opportunities for therapeutic intervention. World J Exp Med 2025; 15(4): 107316
URL: https://www.wjgnet.com/2220-315x/full/v15/i4/107316.htm
DOI: https://dx.doi.org/10.5493/wjem.v15.i4.107316

Rusman RD, Akil F, Parewangi ML, Daud NA, Bachtiar R, Kusuma SH, Rifai A. Gut microbiota and metabolic-associated steatosis liver disease: Unveiling mechanisms and opportunities for therapeutic intervention. World J Exp Med 2025; 15(4): 107316 [PMID: 41497693 DOI: 10.5493/wjem.v15.i4.107316]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.